Definium Therapeutics, Inc. · NASDAQ:DFTX
Definium Therapeutics, Inc. shareholders
As of Jun 30, 2026, 346 institutions reported holding Definium Therapeutics, Inc., 85.4% of its shares. Largest: BlackRock, Capital Group and Avoro Capital Advisors LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Definium Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 11.2M | 8.4% | +2.75M | Aug 7, 2026 |
| Capital Group | 8.33M | 6.2% | new | Aug 12, 2026 |
| Avoro Capital Advisors LLC | 7.19M | 5.4% | +2.19M | Aug 14, 2026 |
| Driehaus Capital Management LLC | 6.85M | 5.1% | +933K | Aug 14, 2026 |
| Jupiter Topco LLC | 5.62M | 4.2% | first report | Aug 14, 2026 |
| Fidelity | 4.75M | 3.5% | +2.94M | Aug 13, 2026 |
| T. Rowe Price | 4.65M | 3.5% | +4.58M | Aug 14, 2026 |
| Vanguard | 4.13M | 3.1% | +1.46M | Aug 13, 2026 |
| Geode Capital | 3.64M | 2.7% | +1.15M | Aug 12, 2026 |
| State Street | 3.07M | 2.3% | +594K | Aug 7, 2026 |